Last updated: 2026-09-30 00:49:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Eli Lilly & Co. (LLY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1,185.38, with a market capitalisation of $1.06T and a P/E ratio of 39.54. Over the past 52 weeks, its price has ranged from $716.08 to $1,292.65. This page covers its latest market performance, valuation, price trends and company information.
$1.06T | |
$1,186.05 | |
$1,292.65 | |
$27.21 | |
$1,184.78 | |
1.20M | |
2.49M | |
39.54 | |
$1,292.65 | |
$716.08 | |
0.55% | |
-- |
Eli Lilly & Co. (LLY) last closed at $1,184.78 as of 2026-09-30 00:01:00, unchanged from the previous close of $1,184.78.
During the latest regular trading session, LLY traded between $27.21 and $1,292.65, with a volume of 1.20M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Eli Lilly & Co. (LLY) moved from $1,164.89 to $1,185.38, representing a gain of 1.76% ($20.49).
The stock traded between $1,134.41 and $1,197.79 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 1.92 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 81.4%
LLY is currently trading at $1,185.38, placing it 81.4% of the way from its 52-week low of $716.08 to its 52-week high of $1,292.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 50000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Eli Lilly & Co. (LLY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.